Concepedia

Jonas S. Heitmann

JS

Statistics

Publications

41

Citations

2.3K

H-Index

21

Active since

2017

Affiliations

University of Tübingen(Current)

Deutsches Konsortium für Translationale Krebsforschung

German Cancer Research Center

University Children's Hospital Tübingen

Heidelberg University

Jonas S. Heitmann is an author at University of Tübingen specializing in immunology, immunotherapy, and cancer immunology.

ORCID

Publications per year

2017–2024

41

Publications

41

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 641 citations · Full text

, , +14

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 275 citations · Full text

, , +17

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 173 citations · Full text

, , +16

Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer

Clemens Hinterleitner, Jasmin Strähle, Elke Malenke et al. · Nature Communications · 2021 · 166 citations · Full text

, , +17

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

Matthias Becker, Monika Strengert, Daniel Junker et al. · Nature Communications · 2021 · 93 citations · Full text

, , +17

1–5 of 41